LSE - Delayed Quote GBp
Arecor Therapeutics plc (AREC.L)
At close: October 25 at 10:09 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,573.00
4,573.00
2,403.00
1,158.00
1,698.00
Gross Profit
--
--
--
1,158.00
1,698.00
Operating Expense
13,748.00
13,748.00
12,915.00
7,597.00
5,126.00
Operating Income
-9,175.00
-9,175.00
-10,512.00
-6,439.00
-3,428.00
Net Non Operating Interest Income Expense
269.00
269.00
88.00
-506.00
-84.00
Pretax Income
-8,901.00
-8,901.00
-10,424.00
-6,945.00
-3,512.00
Tax Provision
-347.00
-347.00
-1,164.00
-776.00
-760.00
Net Income Common Stockholders
-8,554.00
-8,554.00
-9,260.00
-6,169.00
-2,752.00
Diluted NI Available to Com Stockholders
-8,554.00
-8,554.00
-9,260.00
-6,169.00
-2,752.00
Basic EPS
-0.31
-0.00
-0.00
-0.27
-0.10
Diluted EPS
-0.31
-0.00
-0.00
-0.27
-0.10
Basic Average Shares
30,328.12
30,622.62
28,936.09
23,033.42
27,683.53
Diluted Average Shares
30,328.12
30,622.62
28,936.09
23,033.42
27,683.53
Total Operating Income as Reported
-9,175.00
-9,175.00
-10,512.00
-6,439.00
-3,428.00
Total Expenses
13,748.00
13,748.00
12,915.00
7,597.00
5,126.00
Net Income from Continuing & Discontinued Operation
-8,554.00
-8,554.00
-9,260.00
-6,169.00
-2,752.00
Normalized Income
-8,554.00
-8,554.00
-9,260.00
-6,169.00
-2,752.00
Interest Income
284.00
284.00
109.00
1.00
3.00
Interest Expense
15.00
15.00
21.00
22.00
82.00
Net Interest Income
269.00
269.00
88.00
-506.00
-84.00
EBIT
-8,886.00
-8,886.00
-10,403.00
-6,923.00
-3,430.00
EBITDA
-8,390.00
-8,390.00
-10,062.00
-6,752.00
-3,262.00
Reconciled Depreciation
496.00
496.00
341.00
171.00
168.00
Net Income from Continuing Operation Net Minority Interest
-8,554.00
-8,554.00
-9,260.00
-6,169.00
-2,752.00
Total Unusual Items Excluding Goodwill
--
--
--
-462.00
--
Total Unusual Items
--
--
--
-462.00
--
Normalized EBITDA
-8,390.00
-8,390.00
-10,062.00
-6,752.00
-3,262.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 6/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2JQ.DU Gritstone Bio Inc
0.0337
0.00%
BT1.SG Bone Therapeutics SA
0.0103
+30.38%
MWG0.BE InMed Pharmaceuticals Inc
0.2795
+5.47%
MWG0.F InMed Pharmaceuticals Inc.
0.2485
-2.74%
MWG0.SG InMed Pharmaceuticals Inc
0.2980
+12.88%
BT1.F BioSenic S.A.
0.0055
-30.38%
BT1.BE Bone Therapeutics SA
0.0093
+5.68%
1IY0.MU MONOPAR THERAP. NEW
4.8400
0.00%
LMQ.BE Oxford BioDynamics PLC
0.0155
0.00%
2JQ.SG Gritstone bio, Inc.
0.0294
0.00%